Skip to main content

Slide Insurance Holdings, Inc.

For the period ended Sep 30, 2025. Filed Nov 6, 2025.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Sep 30, 2025 · Filed Nov 6, 2025

SLDE$25.94-1.9%Stored close · as of Nov 6, 2026

What changed in Risk Factors?

Read the current filing

The baseline is this issuer’s latest earlier reporting period of the same form that was filed before the current report. A previous 10-Q is a different quarter, not a year-over-year comparison. Amendments are excluded.

Compared 12 previous paragraphs and 12 current paragraphs.

8 unchanged; 1 reworded; 3 added; 3 removed; 0 previous and 0 current paragraphs rearranged.

Tables are not compared: 0 previous and 1 current tables excluded. Dates, whitespace, punctuation and numbering changes are ignored; changes to financial figures remain significant.

A changed paragraph is not evidence that risk increased or decreased. An unchanged paragraph does not establish that risk stayed the same.

Added paragraphs (3)

Current report

Issuer Purchases of Equity Securities

Current report

The following table presents information related to our repurchases of common stock during the third quarter of 2025:

Current report

On August 26, 2025, the Board authorized the repurchase program, which allows the Company to repurchase, from time to time, up to $75.0 million of common stock through open market repurchases in compliance with Rule 10b-18 under the Exchange Act and/or in privately negotiated transactions at management’s discretion based on market and business conditions, applicable legal requirements and other factors. The Company has repurchased 1,406,712 shares of common stock for $20.0 million as of September 30, 2025. Upon repurchase, the Company retired the shares of common stock. The repurchase plan has no time deadline and will continue until all authorized shares have been repurchased or otherwise modified or terminated by the Board.
Removed paragraphs (3)

Previous report

On June 18, 2025, we completed the initial public offering of our common stock pursuant to the Registration Statement which was declared effective by the SEC on June 17, 2025. Pursuant to the Registration Statement, we registered, issued and sold an aggregate of 24.0 million shares of our common stock, of which 16.7 million shares were sold by us and 7.3 million shares were sold by certain selling stockholders named therein at a price to the public of $17.00 per share (for an aggregate offering price of $408.0 million). The Company received net proceeds of approximately $263.5 million, net of approximately $19.8 million of underwriting discounts and commissions. On June 25, 2025, the underwriters fully exercised their option to purchase an additional 3.6 million shares of common stock from certain selling stockholders of the Company at a price of $17.00 per share bringing the aggregate offering price to $469.2 million. The Company did not receive any proceeds from the sale of shares of common stock by selling stockholders. In connection with the IPO, we effectuated an approximately 5.5-for-one stock split of its common stock, preferred stock, vested and unvested stock options and vested and unvested restricted share units. Barclays Capital Inc. and Morgan Stanley & Co. LLC acted as joint book-running managers.

Previous report

We did not make any payments of expenses in connection with the offering to directors, officers or persons owning ten percent or more of any class of our equity securities, or to their associates, or to our affiliates.

Previous report

There has been no material change in the planned use of proceeds from our IPO as described in the related prospectus filed with the SEC pursuant to Rule 424(b)(4) under the Securities Act of 1933, as amended.
Reworded paragraphs (1)

Previous wording

During the three months ended June 30, 2025, no director or officer of the Company adopted orterminated a “Rule 10b5-1 trading arrangement” or “non-Rule 10b5-1 trading arrangement,” as each term is defined in Item 408 of Regulation S-K, nor did the Company during such fiscal quarter adopt or terminate any “Rule 10b5-1 trading arrangement,”

Current wording

During the three months ended September 30, 2025, no director or officer of the Company adopted orterminated a “Rule 10b5-1 trading arrangement” or “non-Rule 10b5-1 trading arrangement,” as each term is defined in Item 408 of Regulation S-K.